SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools

2 years ago

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based…

Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2 years ago

MIAMI, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing…

Senzime Secures Initial TetraGraph Order from Major New York Metropolitan Region University Hospital Group

2 years ago

UPPSALA, SWEDEN / ACCESSWIRE / December 21, 2023 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions,…

IRLAB’s Drug Candidate IRL757 is Phase I Ready

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / December 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 21, 2023 - IRLAB…

Verisante Technology, Inc. Announces 2023 AGM Results

2 years ago

VANCOUVER, BC / ACCESSWIRE / December 20, 2023 / Verisante Technology, Inc. (TSXV:VER.H) (the "Company") is pleased to announce that…

MyndTec Inc. Completes Second Tranche of Non-Brokered Private Placement

2 years ago

Mississauga, Ontario--(Newsfile Corp. - December 20, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in…

Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference

2 years ago

CAMBRIDGE, MA / ACCESSWIRE / December 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced that Jamey Mock, Chief Financial Officer,…

Corporate Governance at Alkermes

2 years ago

NORTHAMPTON, MA / ACCESSWIRE / December 20, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportBoard of DirectorsOur…

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results

2 years ago

Charlotte, North Carolina--(Newsfile Corp. - December 20, 2023) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's…

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

2 years ago

PHOENIX, AZ / ACCESSWIRE / December 20, 2023 / Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a biotechnology company has received…